# Bergamot Blood Lipids Meta-analysis: What the Evidence Says
Canonical: https://www.migaku.app/guides/bergamot-blood-lipids-meta-analysis-evidence-review
Category: evidence-review
Summary: Bergamot Blood Lipids Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mix
Last reviewed: 2026-08-12
Reviewed by: Migaku Evidence Review
# Bergamot Blood Lipids Meta-analysis: What the Evidence Says

## Quick Answer

Bergamot Blood Lipids Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 narrative review, 1 preclinical study.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Functional Foods for Cholesterol Management: A Review of the Mechanisms, Efficacy, and a Novel Cholesterol-Lowering Capacity Index | narrative review | 3 | 2025-08-15 | 10.3390/nu17162648 |
| Efficacy, side effects, adherence, affordability, and procurement of dietary supplements for treating hypercholesterolemia: a narrative review | preclinical study | 4 | 2024-11-19 | 10.1186/s41043-024-00679-0 |

## What The Sources Report

- Hypercholesterolemia (high blood cholesterol) is a well-established risk factor for atherosclerosis and cardiovascular disease (CVD). [Jacobo-Velázquez Daniel A. (2025); evidence level 3]
- Epidemiological data have shown that lowering LDL cholesterol produces a proportional reduction in CVD risk. [Jacobo-Velázquez Daniel A. (2025); evidence level 3]
- From 1990 to 2019, the global prevalence of hypertensive heart disease increased by 137.91%, from 7.82 million to 19.60 million. [von Känel-Cordoba Isabel (2024); evidence level 4]
- The FDA regulates dietary supplements and dietary ingredients, while the European Commission uses EFSA for nutraceutical regulation, allowing health claims based on scientific evidence. [von Känel-Cordoba Isabel (2024); evidence level 4]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

For bergamot blood lipids meta-analysis, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Jacobo-Velázquez Daniel A. (2025). Functional Foods for Cholesterol Management: A Review of the Mechanisms, Efficacy, and a Novel Cholesterol-Lowering Capacity Index. DOI: 10.3390/nu17162648. PMCID: PMC12389712. PMID: 40871675. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12389712/
- von Känel-Cordoba Isabel (2024). Efficacy, side effects, adherence, affordability, and procurement of dietary supplements for treating hypercholesterolemia: a narrative review. DOI: 10.1186/s41043-024-00679-0. PMCID: PMC11575005. PMID: 39563466. License: https://creativecommons.org/licenses/by-nc-nd/4.0/ http://creativecommons.org/licenses/by-nc-nd/4.0/ This article is .... https://pmc.ncbi.nlm.nih.gov/articles/PMC11575005/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.